(Kansas City, MO, White Marsh, MD, Bath, UK) – Evogen, Inc., announced today the appointment of two senior executives to it’s management team to lead the international commercial business efforts for the newly launched EvoCyclerTMHD12 molecular diagnostics platform. This molecular diagnostics and detection instrument provides innovative ultra-rapid PCR amplification and analysis. Kevin McCormack joins Evogen as Vice President, Sales and Marketing, bringing 20 years of international experience establishing and expanding direct sales forces and global distribution networks. Significantly, and most importantly, he has successfully expanded sales in multiple countries across numerous product lines for both consumables and capital equipment. Mr. McCormack held positions from Sales Manager to CEO of companies including Amersham, Imaging Research Inc, Guava Technologies, MDS Sciex and Chip-Man Technologies. Joanne Stephenson joins Evogen as Vice President, Corporate Business Development and Clinical Diagnostics, bringing senior management experience in clinical, environmental and biodefense diagnostics in the areas of business development, sales, and marketing. Joanne served as Vice President, Business Development, Sales and Marketing at Response Biomedical Corporation where she developed and managed global partnerships that lead to the commercialization of more than ten new products. Ms. Stephenson recently served as a senior executive at Innovative Biosensors, Inc., a venture-backed organization, on product entries for the clinical market. “The EvoCycler HD12, combined with our proprietary HyBeacon chemistry, is garnering much interest globally due to it’s affordability, simplicity and excellent performance results without any licensing and use-restriction issues”, said Sean Reineke, Evogen’s President and CEO. “Kevin and Joanne will be able to accelerate our focused efforts on sales expansion of the EvoCycler HD12 as well as establishing relationships with content providers and market channel providers building a network of interested parties with a unique competitive advantage.” The compact EvoCycler™ HD12 is significantly more affordable than comparable instruments with numerous performance advantages. In conjunction with the highly sensitive and specific HyBeacons® PCR chemistry, recently licensed from LGC, Ltd., Evogen now offers the next evolution in High Definition PCR®. The EvoCycler HD12 is an innovative instrument that combines ultra-rapid amplification together with detection within a single integrated platform. Designed for clinical, research, environmental and biodefense applications, the EvoCycler HD12 can process 12 samples in 30 minutes. The operator-intuitive instrument software automates key tasks, from selection of the most appropriate primers and thermal cycling conditions through to auto-calling of results. Evogen’s flagship diagnostic instrument, the EvoCycler HD12, is Evogen’s first commercial entre into the molecular diagnostics market and will be followed by instruments with equally high levels of performance and affordability tailored to meet a range of throughput requirements and customer venues. The product line is focused on customer needs for customization and flexibility. About Evogen (www.evogen.com) Evogen Inc. is the culmination of the merger of two leading independent companies bringing together technologies to meet the ever-evolving needs of the molecular detection and diagnostics industry. Evogen Ltd., a UK molecular diagnostics company and Sceptor Industries, Inc., a US aerosol collection systems company merged to form an entity uniquely positioned to provide accurate, rapid and affordable solutions globally for molecular detection and diagnostics across multiple markets including research, clinical, biodefense, environmental and animal health. Evogen Inc. is globally positioned with offices in Kansas City, MO., White Marsh, MD and Bath, UK. For more information, visit www.evogen.com For more information, contact: Sean Reineke President and Chief Executive Officer Phone: 301.466.2328 Email: sreineke@evogen.com Joanne Stephenson Vice President, Corporate Business Development Phone: 240.688.6615 Email: jstephenson@evogen.com